Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-24-001860
Filing Date
2024-09-18
Accepted
2024-09-18 16:47:53
Documents
1
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3618
  Complete submission text file 0000897069-24-001860.txt   5137
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1430 US HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921
Business Address
Baluch Khoso (Reporting) CIK: 0001686223 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39531 | Film No.: 241308093